Quick Answer
Minerva Neurosciences, Inc. reported Diluted EPS of $34.67 per share (loss) for fiscal year 2025.
Minerva Neurosciences, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$34.67 | -18347.4% |
| 2024 | $0.19 | +104.1% |
| 2023 | -$4.61 | +23.3% |
| 2022 | -$6.01 | +35.7% |
| 2021 | -$9.35 | -18800.0% |
| 2020 | $0.05 | +102.7% |
| 2019 | -$1.85 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.36 | -112.1% | +16.3% |
| June 30, 2025 | -$0.43 | +60.6% | +14.0% |
| March 31, 2025 | -$0.50 | +55.8% | -116.8% |
| September 30, 2024 | $2.97 | +388.3% | +372.5% |
| June 30, 2024 | -$1.09 | +2.7% | +3.5% |
| March 31, 2024 | -$1.13 | +13.7% | -9.7% |
| September 30, 2023 | -$1.03 | +20.2% | +8.0% |
| June 30, 2023 | -$1.12 | +31.3% | +14.5% |
- Minerva Neurosciences, Inc. showed a decrease of -18347.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Minerva Neurosciences, Inc.’s diluted eps has declined by 1774.1% (from $1.85 per share (loss) to $34.67 per share (loss)).
- The most recent figure is from Minerva Neurosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: